Related Experiment Video
Updated: Aug 13, 2026

09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective
Heidi Schulz1, Susan Bigelow, Roxanne Dobish
1Cross Cancer Institute Site, Edmonton, Alberta, Canada. heidis@cancerboard.ab.ca
Summary
Routine monitoring for workplace antineoplastic agent contamination is feasible in pharmacy settings. While most surfaces showed no contamination, exterior vials require attention, indicating a need for ongoing vigilance in cancer drug handling.
Area of Science:
- Occupational Health
- Pharmaceutical Sciences
- Environmental Monitoring
Background:
- Antineoplastic agents pose risks in healthcare settings.
- Workplace contamination requires effective monitoring strategies.
Purpose of the Study:
- To assess the feasibility of routine monitoring for antineoplastic agent contamination.
- To evaluate contamination levels in a pharmacy practice environment.
Main Methods:
- A two-phase feasibility study was conducted.
- Surface samples were analyzed for cyclophosphamide.
- Logistics and financial aspects of monitoring were examined.
Main Results:
- Most tested surfaces were below detection limits for contamination.
- Exterior vial surfaces showed detectable contamination.
- Known contaminated samples confirmed assay validity.
Conclusions:
- Routine monitoring for antineoplastic agents is feasible.
- Increased staff awareness and practice changes were observed.
- Logistics and costs support the adoption of routine monitoring.
Related Concept Videos
Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...